A digital platform layered onto in-person, collaborative care led to clinically meaningful improvement in symptoms of ...

Diarrhea Diarrhea was the most common adverse reaction in two randomized, double-blind, placebo-controlled trials of IBS-C. Severe diarrhea was reported in 2.5% of IBSRELA-treated patients. If severe ...

EnteroBiotix Presents Positive IBS-C Data at Digestive Disease Week® 2025. EBX-102-02 was well tolerated and demonstrated clinically meaningful improvements across multiple sympt ...

IBS can be disruptive and uncomfortable. That's why we consulted gut health experts for their top 10 tips to help ease ...

Medically reviewed by Qin Rao, MD Colon cancer is a type of cancer (abnormal cells growing uncontrollably) that begins in the ...

Blood Test Could Guide Use of Anti-Inflammatory Drug Celecoxib to Reduce Risk of Colon Cancer Recurrence Jan. 28, 2025 — A data analysis from a randomized clinical trial for stage 3 colon cancer ...

GI symptom-related anxiety is a key driver of restrictive eating in IBS and is linked to gut microbiome changes.

Self-help cognitive behavioral therapy for irritable bowel syndrome was successfully delivered via mobile application.

Gastroenterologist Dr. Ali Rezaie explains why this gut disorder is so hard to spot – and which symptoms to look out for.

The illness raises the likelihood that children develop chronic kidney disease, irritable bowel syndrome and cardiovascular ...

The prevalence of irritable bowel syndrome and chronic idiopathic constipation rose significantly during the COVID-19 pandemic.

Digestive issues like IBS and Sibo can mimic each other, but understanding their differences – and the role of our gut ...